Interesting timing with Votrient results due in about 3 weeks. Wonder how good they really are. I am sure they know now and believe they must be good since mentioned in same context as opportunity. Just m o
Oxgn presenting with the big boys in Europe on OCT 24-27. Oxgn listed as both sponsor and presenter along with Roche and several of the big boys. Presenting data on CA4P results as combo with Votrient. Could t be that results were so good that a change of direction is warranted? That would be fabulous would it not?